Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

44.7K
Overview
44.7K
Symbiosis00:58

Symbiosis

28.6K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
28.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A trial-blazer in clinical research.

Immunology and cell biology·2025
Same author

Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease.

mBio·2025
Same author

Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections.

Nature communications·2024
Same author

When academia met industry: working toward a needle-free vaccination future in the sunshine state.

Immunology and cell biology·2024
Same author

A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4<sup>+</sup> T-cell-dependent strain-transcending protective immunity in rodent models.

mBio·2023
Same author

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.

Nature communications·2023
Same journal

Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Review of Quality Attributes and Analytical Methods Used for Comparative Analytical Assessment of Monoclonal Antibodies as Part of Successful Biosimilar Approvals in the United States and European Union.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

An Overview and Trend Analysis of Biosimilar Approvals in China.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
查看所有相关文章

相关实验视频

Updated: Jul 16, 2025

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.4K

疟疾疫苗:迄今为止的进展

Danielle I Stanisic1, Michael F Good2

  • 1Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, QLD, Australia. d.stanisic@griffith.edu.au.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
|September 20, 2023
PubMed
概括
此摘要是机器生成的。

开发有效的疟疾疫苗对于消除疾病至关重要. 虽然RTS,S/AS01推用于儿童,但像R21这样的新候选药物显示出有希望的高水平的有效性对抗Plasmodium falciparum.

更多相关视频

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.0K
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.1K

相关实验视频

Last Updated: Jul 16, 2025

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.4K
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.0K
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.1K

科学领域:

  • 免疫学 免疫学 免疫学
  • 热带医学 热带医学
  • 疫苗学 疫苗学 疫苗学

背景情况:

  • 疟疾是一种蚊子传播的寄生虫疾病,尽管取得了进展,但仍然是全球重大卫生挑战.
  • 开发高效的疟疾疫苗对于疾病控制和根除工作至关重要.
  • 目前的战略需要改善预防和治疗选择,以对抗Plasmodium falciparum.

研究的目的:

  • 审查已经进入临床试验的疟疾疫苗候选人.
  • 突出目前正在开发中的最有前途和最先进的疟疾疫苗候选人.
  • 评估新型疫苗策略在实现长期抗疟疾保护性免疫力方面的潜力.

主要方法:

  • 对疟疾疫苗候选人的临床试验数据的审查.
  • 分析主要候选疫苗的疗效和安全性.
  • 讨论正在进行的疟疾疫苗学研究和开发.

主要成果:

  • RTS,S/AS01 (Mosquirix) 是最先进的疟疾疫苗,推用于非洲儿童.
  • 在III期临床试验中,RTS,S/AS01对临床疟疾具有适度的疗效.
  • 新的候选药物,包括Sanaria的PfSPZ疫苗,PfSPZ-CVac和R21,在临床评估中显示出有希望的结果.
  • 疟疾疫苗候选R21在最近的IIb期试验中表现出高水平的疗效.

结论:

  • 迫切需要更有效的疟疾疫苗来补充现有控制措施.
  • 像R21这样的先进疫苗候选人提供了针对Plasmodium falciparum的改善保护的潜力.
  • 持续的研究和开发对于通过疫苗接种实现疟疾根除至关重要.